Benign and Malignant Tumors of the Liver

Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas

Volumn , Issue , 2009, Pages 1291-1325

  Ferrell, Linda D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957677662     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141604059-0.50050-3     Document Type: Chapter

References (143)

1. Torii A, Harada A, Nonami T, et al. Tumor localization as a prognostic factor in hepatocellular carcinoma. Hepatogastroenterology 1994, 41:16-19.
2. Hamazaki K, Mimura H, Orita K, et al. Surgical treatment for hepatocellular carcinoma (HCC) 3° cm or less than 3° cm in diameter. Hepatogastroenterology 1992, 6:485-588.
3. Schoenthaler R, Phillips T, Castro J, et al. Carcinoma of the extrahepatic bile ducts: The University of California at San Francisco experience. Ann Surg 1994, 219:267-274.
4. Ljung B, Ferrell L Fine needle aspiration biopsy of the liver: Diagnostic problems. Diagnostic Problems in Liver Pathology 1994, 161-9816. Hanley and Belfus, Pathology: State of the Art Reviews. Philadelphia. L. Ferrell (Ed.).
5. Wanless I, Callea F, Craig J, et al. Terminology of nodular lesions of the liver. Hepatology 1995, 25:983-993.
6. Ishak KG, Anthony PP, Sobin LH, et al. Histological Typing of Tumours of the Liver 1994, Springer-Verlag, Berlin. ed 2.
7. Craig J, Peters R, Edmondson H Benign tumors and tumor-like conditions. Tumors of the Liver and Intrahepatic Bile Ducts 1989, 8-902. Armed Forces Institute of Pathology, Washington, DC. W. Hartmann, L. Sobin (Eds.).
8. Wheeler D, Edmondson H, Reynolds T Spontaneous liver cell adenoma in children. Am J Clin Pathol 1986, 85:6-12.
9. Ishak K, Rabin L Benign tumors of the liver. Med Clin North Am 1975, 59:995-1013.
10. Tao L Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma: Cytomorphology and mechanism of malignant transformation. Cancer 1991, 68:341-347.
11. Hytiroglou P, Theise N Differential diagnosis of hepatocellular nodular lesions. Semin Diagn Pathol 1998, 15:285-299.
12. Ferrell L Hepatocellular carcinoma arising in a focus of multilobular adenoma. Am J Surg Pathol 1993, 17:525-529.
13. Bioulac-Sage P, Balabaud C, Bedossa P, et al. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 2007, 46:521-527.
14. Zucman-Rossi J, Jeannot E, Nhieu J, et al. Genotype-phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC. Hepatology 2006, 43:515-524.
15. Bioulac-Sage P, Rebouissou S, Sa Cunha A, et al. Clinical, morphologic and molecular features defining so called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005, 128:1211-1218.
16. Paradis V, Benzekri A, Dargere D, et al. Telangiectatic focal nodular hyperplasia: A variant of hepatocellular adenoma. Gastroenterology 2004, 126:1323-1329.
17. Paradis V, Bieche I, Dargere D, et al. A quantitative bene expression study: A role for angiopoietins in focal nodular hyperplasia. Gastroenterology 2003, 124:651-659.
18. Kong C, Appenzeller M, Ferrell L Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy. Acta Cytol 2000, 44:218-222.
19. Wang XY, Degos F, Dubois S, et al. Glypican-3 expression in hepatocellular tumors: Diagnostic values for preneoplastic lesions and hepatocellular carcinoma. Hum Pathol 2006, in press.
20. Yamauchi N, Watanabe A, Hishinuma M, et al. The glypican-3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol 2005, 18:1591-1598.
21. Shafizadeh N, Ferrell L, Kakar S Glypican-3 expression has low sensitivity for the diagnosis of extremely well-differentiated variants of hepatocellular carcinoma and fibrolamellar carcinoma. Mod Pathol 2007, 20(Suppl).
22. Nguyen B, Flejou J, Terris B, et al. Focal nodular hyperplasia of the liver: A comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999, 23:1441-1454.
23. Tanaka M, Wanless IR Pathology of the liver in Budd-Chiari syndrome: Portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 1998, 27:488-496.
24. Ibarrola C, Casstellano VM, Colina F Focal hyperplastic hepatocellular nodules in hepatic outflow obstruction: A clinicopathological study of four patients and 24 nodules. Histopathology 2004, 44:172-179.
25. Wanless I, Mawdsley C, Adams R On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985, 5:1194-1200.
26. Wanless I, Takayama A Three-dimensional angioarchitecture of focal nodular hyperplasia of liver and hypothesis on the pathogenesis. Mod Pathol 2004, 17(Suppl 1):313A.
27. Tabatabai ZL, Ferrell LD Reticulin, copper, and CD34 staining in the diagnosis of focal nodular hyperplasia. Mod Pathol 2005, 18(Suppl 1):287A.
28. Crawford JM Pathologic assessment of liver cell dysplasia and benign liver tumors: Differentiation from malignant tumors. Semin Diagn Pathol 1990, 7:115-128.
29. Theise N, Lopook J, Thung S A macroregenerative nodule containing multiple foci of hepatocellular carcinoma in a noncirrhotic liver. Hepatology 1993, 17:993-996.
30. Nakanuma Y, Terada T, Ueda K, et al. Adenomatous hyperplasia of the liver as a precancerous lesion. Liver 1993, 13:1-9.
31. Ferrell L, Crawford JM, Dhillon A, et al. Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol 1993, 17:1113-1123.
32. Ferrell L Hepatocellular nodules in the cirrhotic liver: Diagnostic features and proposed nomenclature. Diagnostic Problems in Liver Pathology 1994, 105-9883. Hanley and Belfus, Pathology: State of the Art Reviews. Philadelphia. L. Ferrell (Ed.).
33. Park Y, Yang C-T, Fernandez G, et al. Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. Am J Surg Pathol 1998, 22:656-662.
34. Roncalli M, Roz E, Goggi G, et al. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: Implications for diagnosis and classification. Hepatology 1999, 30:1174-1178.
35. Theise N, Fiel I, Hytiroglou P, et al. Macroregenerative nodules in cirrhosis are not associated with elevated serum or stainable tissue alpha-fetoprotein. Liver 1995, 15:30-34.
36. Sudilovsky O, Sun M, Eshleman J, et al. Preneoplastic lesions of the liver: Molecular pathology and other aspects. Chin J Gastroenterol 1997, 2:254-255.
37. Sun M, Eshleman JR, Ferrell LD, et al. An early lesion in hepatic carcinogenesis: Loss of heterozygosity at the 1p36-p34 region in human cirrhotic livers and dysplastic nodules. Hepatology 2001, 33:1394-1403.
38. Craig J, Peters R, Edmondson H Primary malignant epithelial tumors. Tumors of the Liver and Intrahepatic Bile Ducts 1989, 123-9786. Armed Forces Institute of Pathology, Washington, DC. W. Hartmann, L. Sobin (Eds.).
39. Ishak KG, Goodman ZD, Stocker JT Atlas of Tumor Pathology, Series 3: Tumors of the Liver and Intrahepatic Bile Ducts 1999, American Registry of Pathology and Armed Forces Institute of Pathology, Washington, DC.
40. Goodman Z Tumours and tumour-like lesions of the liver. MacSween's Pathology of the Liver 2006, 761-9186. Churchill Livingstone/Elsevier, London. 5th ed. A. Burt, B. Portmann, L.D. Ferrell (Eds.).
41. Libbrecht L, Roskams T Hepatic progenitor cells in human liver disease. Semin Cell Dev Biol 2002, 13:389-396.
42. Roskams TA, Libbrecht L, Desmet VJ Progenitor cells in diseased human liver. Semin Liver Dis 2003, 23:385-396.
43. Zondervan PE, Wink J, Alers JC, et al. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: Analysis of 26 carcinomas and 12 concurrent dysplasias. J Pathol 2000, 192:207-215.
44. Satyanarayana A, Manns MP, Rudolph I Telomeres and telomerase: A dual role in hepatocarcinogenesis. Hepatology 2004, 40:276-283.
45. Kakar S, Chen X, Burgart LJ, et al. Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular lesions. Mod Pathol 2007, 20(Suppl).
46. Stromeyer F, Ishak K, Gerber M, et al. Ground-glass cells in hepatocellular carcinoma. Am J Clin Pathol 1980, 74:254-258.
47. Edmondson H, Steiner P Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 1954, 1:462-503.
48. Minervini M, Demetris A, Lee R, et al. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997, 10:686-692.
49. Murakata L, Ishak K, Nzeako U Clear cell carcinoma of the liver: A comparative immunohistochemical study with renal clear cell carcinoma. Mod Pathol 2000, 13:874-881.
50. Fan Z, van de Rijn M, Montgomery K, Rouse RV Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue section. Mod Pathol 2003, 16:137-144.
51. Chu PG, Ishizawa S, Wu E, Weiss LM Hepatocyte antigen as a marker of hepatocellular carcinoma: An immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol 2002, 26:978-988.
52. Porcell AI, De Young BR, Proca DM, Frankel WL Immunohistochemical analysis of hepatocellular carcinoma and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers. Mod Pathol 2000, 13:773-778.
53. Morrison C, Marsh W, Frankel WL A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver. Mod Pathol 2002, 15:1279-1287.
54. Fucich L, Cheles M, Thung S, et al. Primary versus metastatic hepatic carcinoma: An immunohistochemical study of 34 cases. Arch Pathol Lab Med 1994, 118:927-930.
55. Maeda T, Kajiyama K, Adachi E, et al. The expression of cytokeratins 7, 19, 20 in primary and metastatic carcinomas of the liver. Mod Pathol 1996, 9:901-909.
56. Wang N, Zee S, Zarbo R, et al. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995, 3:99-107.
57. Rullier A, Le Bail B, Fawaz R, et al. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastases. Am J Surg Pathol 2000, 24:870-876.
58. Chu P, Wu E, Weiss L Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. Mod Pathol 2000, 13:962-972.
59. Garcia de Davila M, Gonzalez-Crussi F, Mangkornkanok M Fibrolamellar carcinoma of the liver in a child: Ultrastructural and immunohistologic aspects. Pediatr Pathol 1987, 7:319-331.
60. Ruck P, Harms D, Kaiserling E Neuroendocrine differentiation in hepatoblastoma: An immunohistochemical investigation. Am J Surg Pathol 1990, 14:847-855.
61. Wang J, Dhillon A, Sankey E, et al. Neuroendocrine differentiation in primary neoplasms of the liver. J Pathol 1991, 163:61-67.
62. Saqi A, Alexis D, Remotti F, Bhagat G Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids. Am J Clin Pathol 2005, 123:394-404.
63. Renshaw A, Granter S A comparison of A103 and inhibin reactivity in adrenal cortical tumors: Distinction from hepatocellular carcinoma and renal tumors. Mod Pathol 1998, 11:1160-1164.
64. Craig J, Peters R, Edmondson H, et al. Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980, 46:372-379.
65. Berman M, Libbey N, Foster J Hepatocellular carcinoma: Polygonal cell type with fibrous stroma-An atypical variant with a favorable prognosis. Cancer 1980, 46:1448-1455.
66. Berman M, Sheahan D Fibrolamellar carcinoma of the liver: An immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol 1988, 19:784-794.
67. Saxena R, Humphreys S, Williams R, et al. Nodular hyperplasia surrounding fibrolamellar carcinoma: A zone of arterialized liver parenchyma. Histopathology 1994, 25:275-278.
68. Saul S, Titelbaum D, Gansler T, et al. The fibrolamellar variant of hepatocellular carcinoma: Its association with focal nodular hyperplasia. Cancer 1987, 60:3049-3055.
69. Kakar S, Burgart L, Batts K, et al. Clinicopathologic features and survival in fibrolamellar carcinoma: Comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol 2005, 18:1417-1423.
70. Goodman Z, Ishak K, Langloss J, et al. Combined hepatocellular-cholangiocarcinoma: A histologic and immunohistochemical study. Cancer 1985, 55:124-135.
71. Allaire G, Rabin L, Ishak K, et al. Bile duct adenoma: A study of 152 cases. Am J Surg Pathol 1988, 12:708-715.
72. Bhathal P, Hughes N, Goodman Z The so-called bile duct adenoma is a peribiliary gland hamartoma. Am J Surg Pathol 1996, 20:858-864.
73. Hornick JL, Lauwers GY, Odze RD Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver. Am J Surg Pathol 2005, 29:381-389.
74. Devaney K, Goodman Z, Ishak K Hepatobiliary cystadenoma and cystadenocarcinoma: A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994, 18:1078-1091.
75. Tsui W, Loo K, Chow L, et al. Biliary adenofibroma. Am J Surg Pathol 1993, 17:186-192.
76. Wee A, Ludwig J, Coffey R, et al. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol 1985, 16:719-726.
77. Chalasani N, Baluyut A, Ismail A, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study. Hepatology 2000, 31:7-11.
78. Honda N, Cobb C, Lechago J Bile duct carcinoma associated with multiple von Meyenburg complexes in the liver. Hum Pathol 1986, 17:1287-1290.
79. Todani T, Watanabe Y, Toki A, et al. Carcinomas related to choledochal cysts with internal drainage operations. Surg Gynecol Obstet 1987, 164:61-64.
80. Chauduri P, Chauduri B, Schuler J, et al. Carcinoma associated with congenital cystic dilatation of bile ducts. Arch Surg 1982, 117:1349-1351.
81. Sameshima Y, Uchimura M, Muto Y, et al. Coexistent carcinoma in congenital dilatation of the bile duct and anomalous arrangement of the pancreatico-bile duct: Carcinogenesis of coexistent gall bladder carcinoma. Cancer 1987, 60:1883-1890.
82. Koga A, Ichimiya H, Yamaguchi K, et al. Hepatolithiasis associated with cholangiocarcinoma. Cancer 1985, 55:2826-2829.
83. Rubel L, Ishak K Thorotrast-associated cholangiocarcinoma. Cancer 1982, 50:1408-1415.
84. Klatskin G Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis: An unusual tumor with distinctive clinical and pathological features. Am J Med 1965, 38:241-256.
85. Sugimachi K, Taguchi T, Aishima S, et al. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Mod Pathol 2001, 14:900-905.
86. Ashida K, Terada T, Kitamura N Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 in human cholangiocarcinoma: An immunohistochemical study. Hepatology 1998, 27:974-982.
87. Taguchi K, Aishima S, Asayama Y, et al. The role of p27kip1 protein expression on the biological behavior of intrahepatic cholangiocarcinoma. Hepatology 2001, 33:1118-1123.
88. Ito Y, Takeda T, Sasaki Y, et al. Bcl-2 expression in cholangiocellular carcinoma is inversely correlated with biologically aggressive phenotypes. Oncology 2000, 59:63-67.
89. Hobbs K Hepatic hemangiomas. World J Surg 1990, 14:468-471.
90. Craig J, Peters R, Edmondson H Benign mesenchymal tumors and tumor-like conditions. Tumors of the Liver and Intrahepatic Bile Ducts 1989, 63-9899. Armed Forces Institute of Pathology, Washington, DC. W. Hartmann, L. Sobin (Eds.).
91. Kane R, Newman A Diffuse skeletal and hepatic hemangiomatosis. Calif Med 1973, 118:41-44.
92. Kim G, Thung SN, Tsui WMS, Ferrell LD Hepatic cavernous hemangioma: Under-recognized associated histologic features. Liver Int 2006, 26:334-338.
93. Goodman Z, Ishak K Angiomyolipomas of the liver. Am J Surg Pathol 1984, 8:745-750.
94. Tsui W, Colombari R, Bonetti F, et al. Hepatic angiomyolipoma: Delineation of unusual morphological variants. Am J Surg Pathol 1999, 23:34-48.
95. Bonetti F, Pea M, Martignoni G, et al. The perivascular epithelioid cell and related lesions. Adv Anat Pathol 1997, 4:343-358.
96. Nakanuma Y, Tsuneyama K, Masuda S, et al. Hepatic inflammatory pseudotumor associated with chronic cholangitis: Report of three cases. Hum Pathol 1994, 25:86-91.
97. Anthony P, Telesinghe P Inflammatory pseudotumor of the liver. J Clin Pathol 1986, 39:761-768.
98. Shek T, Ng I, Chan K Inflammatory pseudotumor of the liver: Report of four cases and review of the literature. Am J Surg Pathol 1993, 17:231-238.
99. Selves J, Meggetto F, Brousset P, et al. Inflammatory pseudotumor of the liver: Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus. Am J Surg Pathol 1996, 20:747-753.
100. Shek T, Ho F, Ng I, et al. Follicular dendritic cell tumor of the liver: Evidence for an Epstein-Barr virus-related clonal proliferation of follicular dendritic cells. Am J Surg Pathol 1996, 20:313-324.
101. Selby D, Stocker J, Ishak K Angiosarcoma of the liver in childhood: A clinicopathologic and follow-up study of 10 cases. Pediatr Pathol 1992, 12:485-498.
102. Craig J, Peters R, Edmondson H Primary malignant mesenchymal tumors. Tumors of the Liver and Intrahepatic Bile Ducts 1989, 223-9745. Armed Forces Institute of Pathology, Washington, DC. W. Hartmann, L. Sobin (Eds.).
103. Ishak K, Sesterhenn I, Goodman Z, et al. Epithelioid hemangioendothelioma of the liver: A clinicopathologic and follow-up study of 32 cases. Hum Pathol 1984, 15:839-852.
104. Gray M, Rosenberg A, Dickersin G, Bhan AK Cytokeratin expression in epithelioid vascular neoplasms. Hum Pathol 1990, 21:212-217.
105. Madariaga J, Marino I, Karavias D, et al. Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol 1995, 2:483-487.
106. Stocker J, Ishak K Mesenchymal hamartoma of the liver: Report of 30 cases and review of the literature. Pediatr Pathol 1983, 1:245-267.
107. Weinberg A, Finegold M Primary hepatic tumors of childhood. Hum Pathol 1983, 14:512-537.
108. Dehner L, Ishak K Vascular tumors of the liver in infants and children: A study of 30 cases and review of the literature. Arch Pathol 1971, 92:101-111.
109. Stanley P, Geer G, Miller J, et al. Infantile hepatic hemangiomas: Clinical features, radiologic investigations, and treatment of 20 patients. Cancer 1989, 64:936-949.
110. Cerar A, Dolenc-Strazar Z, Bartenjev D Infantile hemangioendothelioma of the liver in a neonate: Immunohistochemical observations. Am J Surg Pathol 1996, 20:871-876.
111. Haas J, Muczynski K, Krailo M, et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989, 64:1082-1095.
112. Altmann H Epithelial and mixed hepatoblastoma in the adult. Pathol Res Pract 1992, 188:16-26.
113. Haggitt R, Reid B Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol 1986, 10:871-887.
114. Stocker J Hepatoblastoma. Semin Diagn Pathol 1994, 11:136-143.
115. Abbassi V, Hoy G, Weintraub B HCG production by hepatoblastoma causing isosexual precocious puberty. Pediatr Res 1979, 13:375-381.
116. Wei Y, Fabre M, Branchereau S, et al. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 2002, 19:498-504.
117. Saxena R, Leake J, Shafford E, et al. Chemotherapy effects on hepatoblastoma: A histological study. Am J Surg Pathol 1993, 17:1266-1271.
118. Conran R, Hitchcock C, Waclawiw M, et al. Hepatoblastoma: The prognostic significance of histologic type. Pediatr Pathol 1992, 12:167-183.
119. Ruck P, Kaiserling E Melanin-containing hepatoblastoma with endocrine differentiation: An immunohistochemical and ultrastructural study. Cancer 1993, 72:361-368.
120. Stocker J, Ishak K Undifferentiated (embryonal) sarcoma of the liver: Report of 31 cases. Cancer 1978, 42:336-348.
121. Lack E, Schloo B, Azumi N, et al. Undifferentiated (embryonal) sarcoma of the liver: Clinical and pathologic study of 16 cases with emphasis on immunohistochemical features. Am J Surg Pathol 1991, 15:1-16.
122. Lauwers G, Grant L, Donnelly W, et al. Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma. Am J Surg Pathol 1997, 21:1248-1254.
123. Bove K, Blough R, Soukup S Third report of t(19q)(13.4) in mesenchymal hamartoma of liver with comments on link to embryonal sarcoma. Pediatr Dev Pathol 1998, 1:438-442.
124. Kiani B, Ferrell LD, Qualman S, Frankel WL Immunohistochemical analysis of embryonal sarcoma of the liver. Appl Immunohistochem Mol Morphol 2006, 14:193-197.
125. Scheimberg I, Pollock D, Collins P, et al. Pathology of the liver in leukaemia and lymphoma. Histopathology 1995, 26:311-321.
126. Hubscher S, Lumley M, Elias E Vanishing bile duct syndrome: A possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hepatology 1993, 17:70-77.
127. Jaffe E Malignant lymphomas: Pathology of liver involvement. Semin Liver Dis 1987, 7:257-268.
128. Fried R, Wardzala A, Willson R, et al. Benign cartilaginous tumor (chondroma) of the liver. Gastroenterology 1992, 103:678-680.
129. Hytiroglou P, Linton P, Klion F, et al. Benign schwannoma of the liver. Arch Pathol Lab Med 1993, 117:216-218.
130. Kottke-Marchant K, Hart W, Broughan T Localized fibrous tumor (localized fibrous mesothelioma) of the liver. Cancer 1989, 64:1096-1102.
131. Craig J, Peters R, Edmondson H Tumors of heterotopic tissue and uncertain origin. Tumors of the Liver and Intrahepatic Bile Ducts 1989, 102-9878. Armed Forces Institute of Pathology, Washington, DC. W. Hartmann, L. Sobin (Eds.).
132. Eisen R, Kirby W, O'Quinn J Granular cell tumor of the biliary tree: A report of two cases and a review of the literature. Am J Surg Pathol 1991, 15:460-465.
133. Kudo M, Ikekubo K, Yamamoto K, et al. Focal fatty infiltration of the liver in acute alcoholic liver injury: Hot spots with radiocolloid SPECT scan. Am J Gastroenterol 1989, 84:948-952.
134. Tsui W, Yuen R, Chow L, et al. Solitary necrotic nodule of the liver: Parasitic origin?. J Clin Pathol 1992, 45:975-978.
135. Demirhan B, Sokmensuer C, Karakayali H, et al. Primary extramedullary plasmacytoma of the liver. J Clin Pathol 1997, 50:74-76.
136. Weichhold W, Labouyrie E, Merlio J, et al. Primary extramedullary plasmacytoma of the liver. Am J Surg Pathol 1995, 19:1197-1202.
137. Cozzutto C, Bernardi B, Comelli A, et al. Malignant mesenchymoma of the liver in children: A clinicopathologic and ultrastructural study. Hum Pathol 1981, 12:481-485.
138. Kawarada Y, Uehara S, Noda M, et al. Nonhepatocytic malignant mixed tumor primary in the liver: Report of two cases. Cancer 1985, 55:1790-1798.
139. Parham D, Peiper S, Robicheaux G, et al. Malignant rhabdoid tumor of the liver: Evidence for epithelial differentiation. Arch Pathol Lab Med 1988, 112:61-64.
140. Parham D, Weeks D, Beckwith J The clinicopathologic spectrum of putative extrarenal rhabdoid tumors: An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol 1994, 18:1010-1029.
141. Heaton G, Matthews T, Christopherson W Malignant trophoblastic tumors with massive hemorrhage presenting as liver primary: A report of two cases. Am J Surg Pathol 1986, 10:342-347.
142. Gresham G, Rue L Squamous cell carcinoma of the liver. Hum Pathol 1985, 16:413-416.
143. Nelson V, Fernandes NF, Woolf GM, et al. Primary liposarcoma of the liver: A case report and review of literature. Arch Pathol Lab Med 2001, 125:410-412.